Moderna Applies to FDA for Approval of New Spikevax Formula

Friday, 7 June 2024, 12:47
An update on the latest development from Moderna as they request FDA approval for an enhanced version of their Spikevax vaccine. The new formula holds promise for improved efficacy against evolving variants, potentially impacting global vaccination efforts positively.
https://store.livarava.com/92310a1d-24e7-11ef-a412-9d5fa15a64d8.jpg
Moderna Applies to FDA for Approval of New Spikevax Formula

Moderna Seeks FDA Approval for Updated Spikevax Formula

An exciting update in the medical world as Moderna has submitted its latest version of the Spikevax vaccine to the FDA for review. The new formula is designed to enhance protection against emerging variants of the virus, marking a significant step forward in the fight against COVID-19.

Do you want to advertise here? Contact us
Do you want to advertise here? Contact us
Newsletter

We carefully select news from the world of finance and publish it for our users. We understand the importance of reliable and up-to-date information for people in the financial world. Do you want to receive news in a convenient format and always have it at hand — subscribe to our newsletter and make your analytical work more effective.

Subscribe